PFIZER, INC.

(PFE)
  Report
Real-time Estimate Cboe BZX  -  09:24 2022-08-16 am EDT
49.78 USD   +0.05%
06:43aPfizer Inc. - Statement from Pfizer Chairman and CEO Albert Bourla on Testing Positive for COVID-19
AQ
04:44aDigital innovations and congress coverage led to an increase in all hub users
AQ
08/15Pfizer CEO tests positive for COVID-19, has mild symptoms
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on PFIZER, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) PFIZER, INC.
Analyst Recommendations on PFIZER, INC.
08/09Global Blood Therapeutics Downgraded by RBC to Sector Perform From Outperform, Price Targe..
MT
08/01UBS Adjusts Pfizer Price Target to $59 From $60, Maintains Buy Rating
MT
08/01Barclays Adjusts Pfizer's Price Target to $52 From $50, Keeps Equalweight Rating
MT
07/29SVB Securities Adjusts Pfizer's Price Target to $53 from $55, Keeps Market Perform Rating
MT
07/29PFIZER INC : Goldman Sachs reiterates its Neutral rating
MD
07/13PFIZER INC : Goldman Sachs gives a Neutral rating
MD
07/08Morgan Stanley Adjusts Pfizer's Price Target to $49 From $52, Keeps Equalweight Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 49,75 $
Average target price 56,53 $
Spread / Average Target 13,6%
High Price Target 75,00 $
Spread / Highest target 50,8%
Low Price Target 48,00 $
Spread / Lowest Target -3,52%
Consensus detail
Consensus revision (last 18 months)